The partnership between the Danish pharmaceutical giant and the splashy telehealth firm Hims & Hers was strained from the ...

Big Pharma hates the telehealth startup. Meme-stock day traders love it. Why CEO Andrew Dudum won’t stop selling GLP-1s, no ...

We recently published Market on Mute? Not for These 10 Stocks With Surprising Gains. Hims & Hers Health, Inc. (NYSE:HIMS) is ...

Hims & Hers Health will continue offering low-cost compounded weight-loss shots even after Novo Nordisk terminated their partnership over alleged “deceptive marketing,” CEO Andrew Dudum said in his ...

Hims & Hers Health is a top telehealth company with strong growth, innovation, and global expansion plans. See more on HIMS ...

Investing.com -- Hims & Hers CEO Andrew Dudum has shared new information about the company’s terminated partnership with Novo Nordisk (NYSE: NVO ), which ended in June 2025, in an interview with The ...

Andrew Dudum is a disrupter. In 2017 he founded Hims & Hers (NYSE: HIMS), a digital health startup with the goal of upending the traditional healthcare market.

Hims & Hers CEO and Co-founder Andrew Dudum By Jarrett Banks Hims & Hers Health, Inc. (“Hims & Hers”) just completed its business combination with Oaktree Acquisition Corp. (NYSE: OAC), a SPAC ...

Hims & Hers co-founder and CEO Andrew Dudum spoke on potentially getting into the glucagon-like peptide agonists, or GLP-1, weight loss drug market, how much the company spends marketing to ...

Andrew Dudum, the CEO and 10% Owner of Hims & Hers Health Inc (NYSE:HIMS), has recently sold a significant number of shares in the company. On December 1, 2023, the insider executed a sale of ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ETCompany Participants. Andrew Dudum - Chief Executive Officer Spencer Lee - Chief Financial Officer ...

Andrew Dudum, the co-founder and CEO of telehealth company Hims & Hers, on Monday sought to clarify a recent post on X (formerly Twitter) regarding on-campus protests against the war in Gaza.